MAGEC2 and plasma cell myeloma: MAGE-C2, for example, promoted Warburg effects and hepatocellular carcinoma (HCC) progression [8]; MAGE-C2/CT10 induced spontaneous CD4+ and CD8+ T cell responses in patients with multiple myeloma [9, 10].